NOP-1A: Clinical Trials

3 trials of NOP-1A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 3

Follow NOP-1A: new trials by email Literature Review of NOP-1A trials Research Report on NOP-1A

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[C-11]NOP-1A and Alcohol Use Disorder
[C-11], NOP-1A - Alcohol Use Disorder
Early Phase 1CompletedRajesh Narendran542016-05-272022-07-11
[11C]NOP-1A and Cocaine Use Disorders
[C-11], NOP-1A - Cocaine Use Disorder
Early Phase 1CompletedUniversity of Pittsburgh492014-10-302019-08-05
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A
NOP-1A - Pain, Anxiety
Early Phase 1CompletedNational Institute of Mental Health (NIMH)412010-09-032019-12-17

Conditions studied

Alcoholism (1)  ·  Anxiety Disorders (1)  ·  Depression (1)  ·  Pain (1)

Sponsors

National Institute of Mental Health (NIMH) (1)  ·  Rajesh Narendran (1)  ·  University of Pittsburgh (1)

Countries

United States (3)

Top investigators

Masahiro Fujita, M.D. (1)

NIH funding

R01AA025247 (1), R01DA026472 (1)